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Edited by Vladimir SkulachevAbstract The diuretic drug amiloride and its numerous deriva-
tives are competitive inhibitors of mammalian Na+/H+ antiport-
ers and other eukaryotic antiporters. Most prokaryotic
antiporters, including the major NhaA family of enterobacteria,
are resistant to these compounds. We show that 2-aminoperimi-
dine (AP), a guanidine-containing naphthalene derivative with
some similarity to amiloride, acts as a speciﬁc inhibitor of NhaA
from Escherichia coli. Similar concentrations (IC50 of 0.9 lM)
inhibit the proton motive force dependent Na+(Li+)/H+ exchange
reaction in inside-out sub-bacterial vesicles (at 10 mM NaCl, pH
8) as well as the initial rate of 22Na+/Na+ exchange mediated by
pure NhaA in proteoliposomes. The inhibitor is speciﬁc to NhaA
type antiporters, so AP is a new tool to study the mechanism and
roles of NhaA antiporters of enterobacteria as well as the molec-
ular basis of inhibition by an amiloride-like compound.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Na+/H+ antiporter; NhaA; NhaB; NhaD; NhaA
inhibitor; NhaA-proteoliposomes; 2-Aminoperimidine;
Escherichia coli; Vibrio cholerae1. Introduction
Na+/H+ antiporters are ubiquitous secondary ion transport-
ers residing in the energy-transducing membranes of virtually
all cellular types, including bacterial, animal and plant cells.
They are important for membrane energetics, cytoplasmic
Na+ and pH homeostasis and for the regulation of cellular vol-Abbreviations: Ec-NhaA and Vc-NhaA, Na+/H+ antiporters of NhaA
type from Escherichia coli or Vibrio cholerae, respectively; Ec-NhaB
and Vc-NhaB, Na+/H+ antiporters of NhaB type from Escherichia coli
or Vibrio cholerae, respectively; Vc-NhaD, Na+/H+ antiporter of
NhaD type from Vibrio cholerae; AP, 2-aminoperimidine; TPP+, tet-
raphenyl phosphonium; BTP, bis-Tris-propane; HEPES, 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid; LDB, liposome dilution
buﬀer; IC50, the half maximum inhibitory concentration; DpH, pH
diﬀerence across the membrane; Dw, diﬀerence of electric potentials
across the membrane
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doi:10.1016/j.febslet.2004.11.098ume (for recent reviews, see Refs. [1,2]). The two speciﬁc
Na+(Li+)/H+ antiporters from Escherichia coli, Ec-NhaA and
Ec-NhaB, have been studied extensively (see [2,3] and refer-
ences therein). NhaA is the major antiporter of E. coli [2,3],
Vibrio cholerae [4] and other enterobacteria [2]. It is indispens-
able for the adaptation to high salinity, resistance to Li+ ions
and growth at alkaline pH in the presence of Na+. In addition
to Vc-NhaA and Vc-NhaB, the Ec-NhaA and Ec-NhaB homo-
logs, V. cholerae has an heterologous antiporter, Vc-NhaD [5],
that is present in a number of other bacterial pathogens [6].
There are also many other prokaryotic and eukaryotic Na+/
H+ antiporters that share very little homology with the NhaA
antiporters [2]. These include the eight isoforms, NHE1–8, of
mammalian Na+/H+ antiporters that function to remove ex-
cess of metabolic acids from the cytoplasm to maintain pH
homeostasis of the cells [7].
The diuretic drug amiloride and its numerous derivatives are
competitive inhibitors of mammalian Na+/H+ antiporters
belonging to the NHE family [8]. They have proven to be very
valuable tools in the study of biochemistry, physiology and
pharmacology of these membrane transporters. Amiloride also
inhibits the Na+/H+ antiport in tonoplast and plasmalemma of
higher plants, algae and yeast [9–11]. However, the only bacte-
rial antiporter that is deﬁnitely sensitive to amiloride (with
IC50 = 6 lM, as determined in puriﬁed protein reconstituted
into proteoliposomes) is Ec-NhaB [12]. An earlier report sug-
gests that amiloride may be also eﬀective against the Na+/H+
antiporter of methanogenic bacteria [13]. So far, no speciﬁc
inhibitor has been reported for any member of the major
enterobacterial antiporter family, NhaA.
In this study, we found that AP, an amiloride analog, inhibits,
most probably competitively, the activity of Ec-NhaA with an
IC50 close to 0.9 lM. When assayed in sub-bacterial vesicles,
AP also inhibited the homologous antiporter Vc-NhaA but nei-
ther the heterologous Vc-NhaD nor the Ec-NhaB antiporters.2. Materials and methods
2.1. Bacterial strains and culture conditions
EP432 is an E. coli K-12 derivative, which is melBLid, DnhaA1::kan,
DnhaB::cat, DlacZY, thr1 [14]. TA16 is nhaA+nhaB+lacIQ (TA15lacIQ)
and is otherwise isogenic to EP432 [15]. NM81 is nhaB+ and is other-
wise isogenic to EP432 [16]. O395-N1 is V. cholerae strain kindly pro-
vided by Dr. J.J. Mekalanos, Harvard Medical School [17]. Cells were
grown in L broth (LB) or in modiﬁed L broth (LBK [16]).blished by Elsevier B.V. All rights reserved.
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Plasmid pAXH (previously called pYG10) is a pET20b (Novagen)
derivative encoding His-tagged Ec-NhaA [18]. pBLDL is a pBluescript
II KS+ (Stratagene) derivative encoding Vc-NhaD [5]. pBVA is a
derivative of the same vector containing Vc-nhaA gene with its natural
promoter. The Vc-nhaA was cloned by PCR using chromosomal DNA
from V. cholerae O395-N1 as a template. Primers used were 5 0-A AGC
CGG AAT GGC Ccc TCA GCC TTT TCG GAT GTG G-3 0, intro-
ducing ApaI site (underlined), and 5 0-TTT GGT ATG Gtc GAC
CAG AGT CGA GTT GTG CTT TCA GTG C-3 0, introducing SalI
site (underlined). The PCR fragment was directionally cloned into
pBluescript II KS+ using the introduced restriction sites, and the ﬁdel-
ity of the construct was veriﬁed by DNA sequencing. The plasmid
encoding Ec-NhaB is pEL24, a pUC18 derivative [19].
2.3. Use of AP
AP was prepared in double distilled H20. Since it is a sulfate preci-
pitant, sulfates should be strictly avoided from any reaction mixtures
containing AP.
2.4. Isolation of membrane vesicles and assay of Na+/H+ antiport
activity
Activities of Ec-NhaA, Vc-NhaA and Ec-NhaB were measured in
inside-out vesicles prepared from EP432/pAXH, EP432/pBLDL or
NM81/pEL24 cells, respectively. The Na+/H+ or Li+/H+ antiport activ-
ity was measured with acridine orange, a ﬂuorescent probe for pH dif-
ference across the membrane (DpH) [20,21]. Vesicles (100 lg of
membrane protein) were resuspended in 150 mM KCl, 50 mM bis-
Tris-propane (BTP), 5 mM MgCl2, and 0.5 lM acridine orange and
energized by either D-lactate (2 mM) or ATP (2 mM). The resulting
quenching of the ﬂuorescence was allowed to reach a steady state, at
which point either 10 mM Na+ or 1 mM Li+ was added. Dequenching
of the ﬂuorescence indicated the extrusion of protons from the vesicles
in exchange for the added alkali cations.2.5. Isolation and reconstitution of Ec-NhaA
His-tagged Ec-NhaA was overexpressed in TA16/pAXH cells and
aﬃnity-puriﬁed on Ni2+–NTA–agarose resin (Qiagen) as described in
[18]. For the measurements of 22Na+/Na+ exchange, puriﬁed Ec-NhaA
was reconstituted into proteoliposomes by rapid detergent dilution as
described in [15,22]. Proteoliposomes were formed in liposome dilution
buﬀer (LDB) containing 100 mM potassium acetate, 10 mM NaCl, 2.5
mM MgCl2, and 10 mM Tris–4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid (HEPES), pH 8.0.2.6. Determination of the capacity of the AP cation to create a diﬀusion
potential across membrane
The protocol described in [23] was modiﬁed as follows: liposomes (3
ll) that do not contain Ec-NhaA were prepared loaded with 30 lMAP
in LDB as described above. At zero time, the liposomes were diluted
into 200 ll of LDB buﬀer containing 10 nM [3H] tetraphenyl phospho-
nium (TPP+) (60 nCi/assay). At diﬀerent times, the reaction was
stopped by centrifugation (425 · g, 1 min) through columns (2 ml dis-
posable syringes) containing Sephadex G-50 (ﬁne, Sigma) pre-swollen
in LDB buﬀer and packed by centrifugation (113 · g, 1 min). The
radioactivity retained in liposomes was measured in the ﬂow-through
fractions by liquid scintillation.Fig. 1. 2-Aminoperimidine (AP), structure formulas and diﬀusion
potential created by the AP cation. (A) AP cation (2-perimidinylam-
monium ion) exists in two tautomeric forms, the @NHþ2 tautomer
(structure formula (1)) and the –NHþ3 one (structure formula (2)). The
overall structure of AP resembles that of an R-substituted guanidinium
ion (structure formula (3)), which includes amiloride (structure
formula (4)) and its analogs. (B) AP-loaded liposomes (3 ll) prepared
in LDB were diluted at zero time into 200 ll of LDB buﬀer containing
10 nM [3H] TPP+. At diﬀerent times, the reaction was stopped, the
liposomes separated and the radioactivity retained in them was
determined by liquid scintillation (closed circles). For control,
liposomes were prepared as above but both the loading and dilution
buﬀers contained 30 lM AP, SF6847 (10 lM) and nigericin (0.1 lM)
(empty circles).2.7. Measurements of 22Na+/Na+ exchange in Ec-NhaA proteoliposomes
The 22Na+/Na+ exchange in proteoliposomes was assayed as de-
scribed in [22] with minor modiﬁcations. Prior to measurement, prote-
oliposomes in LDB were pre-equilibrated with 22Na+ (62 lCi/ml), the
desired concentration of AP, the protonophore SF6847 (10 lM) and
the artiﬁcial K+/H+ exchanger, nigericin (0.1 lM) by sonication for
20 seconds twice in a bath sonicator (G1128PIT, Laboratory Supplies
Co., New York). The reaction was initiated by rapid dilution of 4 ll of
proteoliposomes containing 200 ng of Ec-NhaA protein into 1 ml of
the LDB buﬀer supplemented with the above ionophores and the indi-
cated concentrations of AP, but no isotope. Incubation was conducted
at room temperature. To stop the reaction, samples were diluted with
5.0 ml of ice-cold LDB buﬀer, ﬁltered (0.2 lm-ﬁlters, Schleicher and
Schuell) and washed with additional 5.0 ml of the buﬀer.2.8. Materials
22Na+ (carrier-free) was from PerkinElmer Life & Analytical Sci-
ences; SF6847 and nigericin were from Sigma. AP was from Aldrich
(Cat. # 23,212-2).3. Results and discussion
A large family of inhibitors of mammalian Na+/H+ antiport-
ers includes the R-substituted guanidinium ions such as amilo-
ride (Fig. 1, structure formulas (3) and (4)) and its analogs [8].
The ability of amiloride-type compounds to inhibit Na+/H+
antiporters is due to the presence of the small guanidine group,
which mimics structurally the tri-hydrated Na+ ion and thus
can compete with Na+ for the alkali cation-binding site of
the antiporter [8,24]. In spite of extensive screening of many
of the common amiloride derivatives, none have been found
to inhibit Ec-NhaA ([12] and unpublished results). These neg-
ative results could be interpreted in two ways: (a) The Na+
binding site of Ec-NhaA is diﬀerent from that of the amiloride
sensitive antiporters. (b) The Na+ binding site of Ec-NhaA is
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accessible to the amilorides. By serendipity, we came across AP
and noticed its similarity to amiloride, in that both compounds
contain a guanidine group (Fig. 1).
3.1. Properties of AP
The AP molecule, a known sulfate precipitant and potent
inhibitor of cholinesterases [25], consists of a guanidine group
fused to a naphthalene moiety (Fig. 1, structure formulas (1)
and (2)). Crystallographic studies [26] showed that AP existsFig. 2. The eﬀect of AP on the antiporter activity of Ec-NhaA in
inside-out membrane vesicles. EP432 cells transformed with plasmid
pAXH were grown in LBK and inside-out membrane vesicles were
isolated. The DpH was monitored with acridine orange at pH 7.5 in a
reaction mixture (2.5 mL) containing: 50 lg of membrane protein, 0.5
lM acridine orange, 150 mM KCl, 50 mM BTP and 5 mMMgCl2. (A,
B) At the onset of the experiment, AP at the indicated concentrations
was added to the reaction mixtures (ﬁrst arrow pointing up), followed
by membranes (ﬁrst arrow pointing down) and lactate (1.6 mM)
(second arrow pointing down) and ﬂuorescence quenching was
recorded until a steady state level of DpH had been reached (100%).
NaCl (10 mM in A) or LiCl (1 mM in B) was then added (second
arrow pointing up), and the new steady state level of ﬂuorescence
obtained (dequenching) was monitored. All experiments were repeated
at least three times and the results were essentially identical. (C) The
reaction was conducted as in (A) but the pH was 8 and 30 lM AP was
added after the respiratory driven DpH had been established (the ﬁrst
arrow pointing up). (D) The same experiment as in (C) but Tris–ATP
(2 mM) was used to energize the membrane. (E) For calculation of the
IC50 of AP inhibition, the activity of the antiporter (in percent
dequenching; 100% corresponds to the activity in the absence of AP)
was plotted versus AP concentration. The IC50 values for the
inhibition in the presence of 10 mM Na+ or 1 mM Li+ were 1 and 2
bas a cation (2-perimidinylammonium ion) in two tautomeric
forms, the @NHþ2 tautomer (Fig. 1, structure formula (1)) and
the –NHþ3 one (Fig. 1, structure formula (2)). Since AP has a
pKa of 9.5, it would be mostly cationic at the physiological pH
range. The hydrophobic naphthalene moiety of AP (Fig. 1) sug-
gests that the cationic AP is membrane permeable. Indeed, upon
dilution of liposomes pre-loadedwithAP to anAP freemedium,
the ‘‘downhill’’ ﬂow of AP induced a diﬀusion potential (nega-
tive inside) which drove the uptake of the permeable radioac-
tively labeled TPP+ (Fig. 1B, closed circles). Addition of the
protonophore SF6847 in combination with nigericin and AP
(in concentrations equivalent to that of loading) to the experi-
mental buﬀer abolished the uptake of TPP+ due to the dissipa-
tion of the diﬀusion Dw (diﬀerence of electric potentials across
the membrane) (Fig. 1B, empty circles). The hydrophobic nat-
ure ofAPand its similarity to amilorides led us to study the eﬀect
of AP on the Na+/H+ antiporter activity of Ec-NhaA.
3.2. AP inhibits the energy dependent Na+/H+ antiporter activity
of Ec-NhaA in sub-bacterial vesicles
To test the eﬀect of AP on Ec-NhaA antiport activity, we
ﬁrst used inside-out membrane vesicles isolated from EP432
transformed with plasmid pAXH. EP432 lacks the chromo-
somal encoded antiporters Ec-NhaA and Ec-NhaB [12], and
expresses His-tagged Ec-NhaA from the plasmid [18]. Upon
addition of the respiratory substrate, lactate, to these mem-
branes, DpH was generated as monitored by the quenching
of ﬂuorescence of acridine orange, a ﬂuorescence probe of
DpH ([20] and Fig. 2A). Addition of 10 mM Na+ to the reac-
tion mixture initiated the DpH driven Na+/H+ antiporter activ-
ity of Ec-NhaA as monitored by the dequenching of the
ﬂuorescence (Fig. 2A, trace 0.0 AP). AP, at concentrations be-
low 20 lM, had no eﬀect on the respiratory driven DpH (Fig.
2A and data not shown). However, much lower concentrations
of AP (0.3–6.0 lM) inhibited the Na+/H+ antiport mediated by
Ec-NhaA in a concentration-dependent manner (Fig. 2A and
data not shown).
The apparent Km for Li
+ of Ec-NhaA is 10-fold lower than
that for Na+ (0.02 mM and 0.2 mM at pH 8.0, respectively
[27]). Accordingly, the Li+/H+ antiport activity of NhaA, mea-lM, respectively.
Fig. 3. The eﬀect of AP on the 22Na+/Na+ exchange catalyzed by Ec-
NhaA reconstituted into proteoliposomes. (A) His-tagged Ec-NhaA
was puriﬁed, reconstituted into proteoliposomes and the proteolipo-
somes were pre-equilibrated with 22Na+ and the respective AP
concentrations as described under Section 2. Samples were ﬁltered at
diﬀerent times of incubation and the amount of radioactivity retained
on the ﬁlters was counted. AP concentrations were: 0.0 lM (control),
empty circles; 1.0 lM, closed diamonds; 6.0 lM, empty squares; 30
lM, closed triangles. All points are averages of at least two
measurements. (B) For calculation of the IC50 of AP inhibition, the
initial rate of the 22Na+/Na+ exchange mediated by Ec-NhaA in
proteoliposomes was plotted versus AP concentration. The experiment
was done in triplicates. The IC50 for the inhibition was 0.9 lM AP.
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similar to those inhibiting the Na+/H+ antiport activity (Fig.
2B). At higher concentration of Li+ (10 mM), the eﬀect of
AP was barely detectable (data not shown). Taken together,
these results highly suggest that AP inhibits Ec-NhaA speciﬁ-
cally and competitively.
In Fig. 2E, the Na+/H+ activity of Ec-NhaA (in percentage
of dequenching) is plotted as a function of AP concentrations
at pH 7.5, yielding a linear dependence with an IC50 of 0.9 lM
AP for the Na+/H+ antiport activity (at 10 mMNa+) and 2 lM
AP for the Li+/H+ antiport activity (at 1.0 mM Li+).
It should be noted that at concentrations higher than 20 lM,
AP provoked a collapse of the DpH generated across the mem-
brane, irrespective of the molecular mechanism of proton
pumping (respiration, Fig. 2C, or ATPase reaction, Fig. 2D).
Hence, at these concentrations AP either collapses the perme-
ability barrier of the membrane or, similar to uncouplers, col-
lapses the proton motive force across the membrane. We prefer
the latter alternative for the following reasons: (a) There was
no sign of membrane destruction. For example, liposomes
(without proteins) prepared and loaded with 10 mM 22Na as
for the Na+/Na+ exchange reaction but diluted into similar
medium without the radioactive label retained the radioactiv-
ity for at least 3 min, and AP up to 30 lM had hardly any ef-
fect (control for the exchange reaction, see below). (b) AP is a
weak amine that, in its un-ionized form, can freely penetrate
the membrane, collapse the DpH and change the internal
pH. As shown above (Fig. 1B), AP also exists as a hydropho-
bic cation. Therefore, at suﬃcient concentrations it would col-
lapse the Dw. Both eﬀects, at the pH used, would result in a
complete collapse of the proton motive force created across
the membrane. Being a weak amine and a penetrating cation,
AP at high concentrations can dissipate both DpH and Dw.
Similar behavior has previously been documented in mem-
brane vesicles for amiloride and some of its derivatives [28,29].
3.3. AP inhibits the22Na+/Na+ exchange in Ec-NhaA
proteoliposomes
The above data have clearly indicated that at low micromo-
lar concentrations, AP acts as a speciﬁc inhibitor of the Na+/
H+ antiporter activity of Ec-NhaA in its energy dependent
mode. Therefore, it was very important to examine whether
an energy-independent partial reaction of the catalytic cycle
of Ec-NhaA, namely Na+/Na+ exchange, is sensitive to AP.
We have previously studied the parameters of this reaction
in puriﬁed Ec-NhaA proteoliposomes [22]. This reaction in-
cludes binding and de-binding of Na+ at opposite sides of
the membrane and translocation of the loaded antiporter
across the lipid bilayer. It could be monitored as 22Na+/Na+
exchange [22]. For this purpose, proteoliposomes pre-equili-
brated with 22Na+ are diluted into isotope-free buﬀer of the
same composition as that in the liposomal interior. Then, the
exchange reaction is monitored by determination of the pro-
gressive loss, over time, of the radiolabeled cation from the
proteoliposomes. Since Ec-NhaA is an electrogenic antiporter,
exchanging 2H+ per Na+ [1,3], the reaction is carried out in the
presence of both the protonophore (SF6847) and nigericin (in
the presence of K+) to eliminate generation of either DpH or
Dw across the membrane. As shown previously ([22] and in
Fig. 3A (trace –––)), the exchange reaction was very fast;
within half a minute, equilibrium distribution of the 22Na+
was reached. In the control experiment with liposomes notcontaining Ec-NhaA, addition of AP was without eﬀect for
at least 3 min (data not shown). AP inhibited the 22Na+/Na+
exchange reaction in a concentration dependent manner,
reaching complete inhibition at 30 lM (Fig. 3B).
Plotting of the initial rate of 22Na+/Na+ exchange in proteo-
liposomes versus the concentration of AP (Fig. 3B) gave an
IC50 for AP of 0.9 lM. Hence, AP inhibits the energy indepen-
dent Na+/Na+ exchange and the energy coupled reaction of the
cation–proton exchange with a similar IC50 (see Fig. 2E). Since
AP inhibits the partial reaction of the overall antiport, namely
Na+/Na+ exchange (Fig. 3B), and other amiloride derivatives
are known to compete with substrate cations, we hypothesize
that AP acts as a competitive inhibitor. This idea is also sup-
ported by the observations that similar inhibition patterns
were obtained when 10-fold excess of Na+ over Li+ was used
to measure antiport in subbacterial vesicles (Fig. 2E), i.e., cor-
relating with the Km of Ec-NhaA for the two alkali cations.
3.4. Antiporter speciﬁcity of AP
To examine the antiporter speciﬁcity of AP, we repeated the
experiments described in Fig. 2 using inside-out subbacterial
vesicles isolated from cells of E. coli expressing the NhaA
homolog Vc-NhaA or the diﬀerent Na+/H+ antiporters, Vc-
NhaD or Ec-NhaB. As expected, Vc-NhaA was sensitive to
AP. Determination of IC50 gave 3.4 lM for 10 mM Na
+ and
Vc-NhaA
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Fig. 4. AP speciﬁcally inhibits antiporters of the NhaA type. (A) AP
inhibits the Na+/H+ antiport (open circles) and Li+/H+ antiport (closed
circles) in inside-out membrane vesicles isolated from the EP432 cells
expressing Vc-NhaA. Measurements were done and data plotted as
speciﬁed in the legend for Fig. 2. (B) Vc-NhaD is resistant to AP.
Measurements were carried out under the same conditions using the
vesicles isolated from the EP432 cells expressing Vc-NhaD. Open
circles, Na+/H+ antiport; closed circles, Li+/H+ antiport.
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similar cation binding site of the two homologous antiporters.
However, the cation–proton antiport was unaﬀected by the
inhibitor in the case of Vc-NhaD (Fig. 4B) or Ec-NhaB (data
not shown). Thus, AP speciﬁcally inhibits bacterial Na+/H+
antiporters of NhaA type.
The discovery of a speciﬁc inhibitor of NhaA-type antiport-
ers provides a new tool to study ligand–protein interactions of
this class of membrane proteins and their primary role in
homeostasis of pH and Na+ in enterobacteria. Furthermore,
since AP is an amiloride analog this study opens a new way
to study the molecular basis of inhibition of an amiloride
drug-like compounds.
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